不同升压药输注对剖宫产母婴结局的疗效与安全性:随机对照试验的系统综述与网络Meta分析
该系统综述与网络Meta分析纳入55项随机对照试验共5487例腰麻或腰硬联合麻醉下剖宫产患者,比较预防性升压药输注的母婴结局。去氧肾上腺素、去甲肾上腺素、间羟胺和肾上腺素在预防低血压方面明确优于对照;间羟胺和甲氧明对脐带血气酸碱平衡保护更优。
要点
- 去氧肾上腺素、去甲肾上腺素、间羟胺和肾上腺素预防剖宫产腰麻后低血压明确优于无升压药对照。
- 间羟胺和甲氧明对脐动脉和脐静脉酸碱平衡的保护优于其他药物。
- 含轻度β活性的α激动剂(如去甲肾上腺素、间羟胺)预防低血压优于麻黄碱。
核心结论
- 连续输注含轻度β活性的α激动剂(如去甲肾上腺素、间羟胺)在预防产妇低血压方面优于麻黄碱等混合肾上腺素能激动剂。
- 胎儿结局的证据基础仍然有限。
研究设计与样本
- 系统综述与网络Meta分析,纳入55项随机对照试验,共5487例在腰麻或腰硬联合麻醉下接受剖宫产的正常血压成人患者。
- 通过综合数据库检索识别评估预防性升压药输注母婴结局的随机对照试验。
主要发现
- 主要结局为产妇低血压发生率和脐动脉碱剩余。
- 间羟胺、去甲肾上腺素、去氧肾上腺素和肾上腺素四种药物在预防低血压方面被判为明确优于对照(无活性升压药输注)。
- 脐血管分析显示甲氧明和间羟胺对脐动脉和脐静脉酸碱平衡的保护均更优。
- 次要结局包括脐动静脉pH、脐静脉碱剩余、1分钟和5分钟Apgar评分及产妇术中恶心呕吐、心动过缓、心动过速和高血压发生率。
关键数值与推荐
- 共55项试验、5487例患者纳入最终分析。
- 四种药物(间羟胺、去甲肾上腺素、去氧肾上腺素、肾上腺素)在预防低血压方面明确优于对照。
- 甲氧明和间羟胺对脐动脉和脐静脉酸碱平衡的保护更优。
临床怎么用
- 剖宫产腰麻下预防性升压可优先考虑含轻度β活性的α激动剂连续输注,如去甲肾上腺素或间羟胺。
- 甲氧明和间羟胺可能更有利于胎儿脐带酸碱平衡,但胎儿结局证据仍有限。
局限性
- 胎儿结局的证据基础仍然有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Phenylephrine infusion is widely endorsed by guidelines as the preferred prophylactic drug for spinal hypotension in patients undergoing caesarean delivery; however, clinical practice continues to show marked variability in the selection of vasopressor drugs. To address this, we aimed to synthesise current evidence from randomised controlled trials comparing vasopressor infusions for various feto-maternal outcomes in normotensive adult patients undergoing caesarean delivery. METHODS: Randomised controlled trials evaluating maternal and fetal outcomes associated with prophylactic vasopressor infusion were identified through comprehensive database searches. Primary outcomes were the incidence of maternal hypotension and umbilical artery base excess. Secondary outcomes comprised maternal and fetal parameters including: umbilical artery and vein pH; umbilical vein base excess; Apgar scores at 1 min and 5 min; and incidence of maternal intra-operative nausea and vomiting, bradycardia, tachycardia and hypertension. RESULTS: Fifty-five trials involving 5487 patients undergoing caesarean delivery under spinal or combined spinal and epidural anaesthesia using a variety of vasopressor infusions were included in the final analysis. Four drugs-metaraminol, noradrenaline, phenylephrine and adrenaline-were judged to be 'definitely superior' to control (no active vasopressor infusion) for the prevention of hypotension. Umbilical vessel analyses indicated that mephentermine and metaraminol provided superior preservation of both umbilical arterial and venous acid-base balance. DISCUSSION: Current evidence suggests that continuous infusions of α-agonists with mild β-activity (e.g. noradrenaline, metaraminol) are preferable to mixed adrenergic agonists such as ephedrine for preventing maternal hypotension. While these findings reinforce existing recommendations for maternal haemodynamic management, the evidence base for fetal outcomes remains limited. WHAT WE DID: We looked at many research studies where doctors gave medicines to stop low blood pressure during caesarean births. These medicines help keep the mother's blood pressure steady after a spinal anaesthetic. We compared different medicines to see how they affected: mothers' blood pressure and side effects, and babies' health at birth (using blood tests and Apgar scores). In total, we studied results from over 5000 women in 55 research trials. WHY DID WE DO IT: Low blood pressure is common during caesarean births with spinal anaesthetic and can make mothers feel sick and unwell. Doctors use medicines to prevent this, but different hospitals use different drugs. We wanted to find out which medicines work best and are safest for both mothers and babies. WHAT WE FOUND: We found that four medicines worked well to stop low blood pressure: phenylephrine, noradrenaline, metaraminol and adrenaline. Some medicines (especially metaraminol and mephentermine) were better at keeping babies' blood tests healthy. Medicines like noradrenaline and metaraminol worked better overall than older drugs such as ephedrine. These better medicines helped keep mothers' blood pressure steady and reduced sickness and vomiting. This means that using certain modern medicines is likely safer and more effective for mothers during caesarean birth and may also help protect babies—although more research is still needed for babies' outcomes.
引用
- Singh NP, Makkar JK, Khurana BJK, et al. Efficacy and safety of different vasopressor infusions on feto-maternal outcomes in normotensive patients undergoing caesarean delivery: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia. 2026. PMID: 41854017. doi:10.1111/anae.70204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。